Alpha 2.0
Login Register
» Authors » Scott Waldman

Scott Waldman

Explore the profile of Scott Waldman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 367
Followers 0
Related Specialties
Pharmacology
General Medicine
Biochemistry
Top 10 Co-Authors
Andre Terzic
Terry Hyslop
Dariouch Dolatabadi
Victor Legrand
Miodrag Ostojic
Badih El Nakadi
Marc Vanderheyden
Jean Louis Vanoverschelde
Mathias Vrolix
Marko Banovic
Published In
J Am Coll Cardiol
Antimicrob Agents Chemother
Anal Biochem
Clin Transl Sci
Nat Rev Drug Discov
Affiliations
Soon will be listed here.
Recent Articles
1.
Biomarkers in the development of individualized treatment regimens for colorectal cancer
Crutcher M, Waldman S
Front Med (Lausanne) . 2022 Dec; 9:1062423. PMID: 36530921
Introduction: Colorectal cancer (CRC) is the third most common and second most deadly malignancy in the world with an estimated 1. 9 million cases and 0.9 million deaths in 2020....
2.
NHERF3 is necessary for heat-stable enterotoxin-induced inhibition of NHE3: differences in signaling in mouse small intestine and Caco-2 cells
Chen T, Lin R, Avula L, Sarker R, Yang J, Cha B, et al.
Am J Physiol Cell Physiol . 2019 Aug; 317(4):C737-C748. PMID: 31365292
Enterotoxigenic (ETEC) is a leading cause of childhood death from diarrhea and the leading cause of Traveler's diarrhea. heat-stable enterotoxin (ST) is a major virulence factor of ETEC and inhibits...
3.
Policies to aid the adoption of personalized medicine
Nofziger C, Papaluca M, Terzic A, Waldman S, Paulmichl M
Nat Rev Drug Discov . 2014 Mar; 13(3):159-60. PMID: 24577385
No abstract available.
4.
Reply: The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE)
Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, et al.
J Am Coll Cardiol . 2013 Dec; 62(25):2454-2456. PMID: 24355591
No abstract available.
5.
Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics
Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, et al.
J Am Coll Cardiol . 2013 Apr; 61(23):2329-38. PMID: 23583246
Objectives: This study sought to evaluate the feasibility and safety of autologous bone marrow-derived and cardiogenically oriented mesenchymal stem cell therapy and to probe for signs of efficacy in patients...
6.
Colorectal cancer stem cells as biomarkers: where it all starts?
Avital I, Summers T, Steele S, Waldman S, Nissan A, Bilchik A, et al.
J Surg Oncol . 2013 Mar; 107(8):791-3. PMID: 23512573
No abstract available.
7.
Chronic diseases: the emerging pandemic
Terzic A, Waldman S
Clin Transl Sci . 2011 Jun; 4(3):225-6. PMID: 21707955
No abstract available.
8.
Targeted diagnostics and therapeutics for individualized patient management
Waldman S, Terzic A
Biomark Med . 2010 May; 1(1):3-8. PMID: 20477454
No abstract available.
9.
Relative quantification based on logistic models for individual polymerase chain reactions
Chervoneva I, Li Y, Iglewicz B, Waldman S, Hyslop T
Stat Med . 2007 Oct; 26(30):5596-611. PMID: 17968873
The quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) technology measures molecular variations in specific biomarkers. Relative quantification determines the target expression relative to an external standard or reference sample...
10.
Statistical algorithm for assuring similar efficiency in standards and samples for absolute quantification by real-time reverse transcription polymerase chain reaction
Chervoneva I, Hyslop T, Iglewicz B, Johns L, Wolfe H, Schulz S, et al.
Anal Biochem . 2005 Dec; 348(2):198-208. PMID: 16336939
Reverse transcription (RT) followed by the polymerase chain reaction (PCR) is the method of choice for quantifying rare transcripts in biological samples. A key assumption underlying the absolute quantification of...